Tech Company Financing Transactions
Familiar Therapeutics Funding Round
Pioneer Fund, Icehouse Ventures and private investors participated in a $5 million Seed funding round for Familiar Therapeutics. The round was announced on 10/22/2026.
Transaction Overview
Company Name
Announced On
10/22/2026
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
Pioneer Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to move its lead programs into clinical studies and advance its pipeline of animal therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
740 Broadway Street
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Undisclosed
Website
Email Address
Overview
Familiar Therapeutics is a biotechnology company bringing medicines first developed for people to dogs and cats. Dogs and cats develop many of the same diseases as people, often driven by the same biology. Human medicine has made huge advances in treating those diseases, but very little of that progress has reached pets, and for many serious conditions they have very few or no options. Our goal is to give vets and pet owners proven, FDA-approved, disease-modifying treatments for serious conditions in dogs and cats.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elizabeth Iorns
Chief Operating Officer
Dan Knox
VP - Regulatory Affairs
Stacy Ross
Browse more venture capital transactions:
Prev: 10/22/2026: Whop venture capital transaction
Next: 10/22/2026: Ultra Security venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs